A medical bioscience study of serum levels of paraoxonase 1 activity and total antioxidant capacity relationship with anti-mullerian hormone in polycystic ovary syndrome
  • Article Type: Research Article
  • Eurasian Journal of Biosciences, 2019 - Volume 13 Issue 1, pp. 595-599
  • Published Online: 12 May 2019
  • Article Views: 20 | Article Download: 16
  • Open Access Full Text (PDF)
AMA 10th edition
In-text citation: (1), (2), (3), etc.
Reference: Jabbar RM, Ahmed BA, Jawad ES. A medical bioscience study of serum levels of paraoxonase 1 activity and total antioxidant capacity relationship with anti-mullerian hormone in polycystic ovary syndrome. Eurasia J Biosci. 2019;13(1), 595-599.

APA 6th edition
In-text citation: (Jabbar et al., 2019)
Reference: Jabbar, R. M., Ahmed, B. A., & Jawad, E. S. (2019). A medical bioscience study of serum levels of paraoxonase 1 activity and total antioxidant capacity relationship with anti-mullerian hormone in polycystic ovary syndrome. Eurasian Journal of Biosciences, 13(1), 595-599.

Chicago
In-text citation: (Jabbar et al., 2019)
Reference: Jabbar, Roaa Mohammed, Batool Ali Ahmed, and Enaas Saleh Jawad. "A medical bioscience study of serum levels of paraoxonase 1 activity and total antioxidant capacity relationship with anti-mullerian hormone in polycystic ovary syndrome". Eurasian Journal of Biosciences 2019 13 no. 1 (2019): 595-599.

Harvard
In-text citation: (Jabbar et al., 2019)
Reference: Jabbar, R. M., Ahmed, B. A., and Jawad, E. S. (2019). A medical bioscience study of serum levels of paraoxonase 1 activity and total antioxidant capacity relationship with anti-mullerian hormone in polycystic ovary syndrome. Eurasian Journal of Biosciences, 13(1), pp. 595-599.

MLA
In-text citation: (Jabbar et al., 2019)
Reference: Jabbar, Roaa Mohammed et al. "A medical bioscience study of serum levels of paraoxonase 1 activity and total antioxidant capacity relationship with anti-mullerian hormone in polycystic ovary syndrome". Eurasian Journal of Biosciences, vol. 13, no. 1, 2019, pp. 595-599.

Vancouver
In-text citation: (1), (2), (3), etc.
Reference: Jabbar RM, Ahmed BA, Jawad ES. A medical bioscience study of serum levels of paraoxonase 1 activity and total antioxidant capacity relationship with anti-mullerian hormone in polycystic ovary syndrome. Eurasia J Biosci. 2019;13(1):595-9.

Abstract

The medical bioscience aims at training and developing scientists who will conduct research with a view to reduce the many lifestyle associated sicknesses. Polycystic ovary disease (PCOS) is a multifactorial disease and its prevalence rate increased significantly in the last few years. It is considered a cause of infertility and delayed reproduction, in addition to the many complications associated with the disease, which affect the lives of the patients in many aspects. During the study of the most important factors related to disease it is clear that the rise in AMH is indicative of degree of severity of disease, where it reflects the number of small follicles in the ovary. Hyperinsulinemia and insulin resistance with hyper- androgenemia conditions associated with PCOS enters the patients in vicious circle of factors where there is an increase in oxidative stress and decrease in antioxidants, including PON-1 and TAOC as the results showed, this in turn more increases the resistance of insulin and high level of testosterone followed by various complications on the heart and fertility and obesity and others. Serum AMH and PON-1was measured using enzyme linked immunosorbent kit [Elisa], while FSH, LH, testosterone, prolactin and estradiol were determined by VIDAS kit method (enzyme linked fluorescent assay) and TAOC measured by colorimetric method.

References

  • Alanbay I, Ercan CM, Sakinci M, Coksuer H, Ozturk M, Tapan S (2012) A macrophage activation marker chitotriosidase in women with PCOS: does low-grade chronic inflammation in PCOS relate to PCOS itself or obesity? Archives of gynecology and obstetrics, 286(4): 1065-71. https://doi.org/10.1007/s00404-012-2425-0
  • Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, Lizneva D, Natterson-Horowtiz B, Teede HJ, Yildiz BO (2016) Polycystic ovary syndrome. Nature Reviews Disease Primers, 2: 16057. https://doi.org/10.1038/nrdp.2016.57
  • Bilman FB, Yetik M (2017) Geotrichum candidum: A rare infection agent at urinary system and review of the literature. J Clin Exp Invest., 8(4): 127-9. https://doi.org/10.5799/jcei.382434
  • Binazir MB, Alizadeh M, Nikasa P, Azhough R, Movassaghi R (2016) The Effect of a Modified World Health Organization Surgical Safety Checklist on Postoperative Complications in a Tertiary Hospital in Iran. European Journal of General Medicine, 13(1): 21-7. https://doi.org/10.15197/ejgm.01442
  • Blair SA, Kyaw-Tun T, Young IS, Phelan NA, Gibney J, McEneny J (2013) Oxidative stress and inflammation in lean and obese subjects with polycystic ovary syndrome. The Journal of reproductive medicine, 58(3-4): 107-14.
  • Chistiakov DA, Melnichenko AA, Orekhov AN, Bobryshev YV (2017) Paraoxonase and atherosclerosis-related cardiovascular diseases. Biochimie, 132: 19-27. https://doi.org/10.1016/j.biochi.2016.10.010
  • Dadachanji R, Shaikh N, Patil A, Shah N, Mukherjee S (2018) PON1 promoter polymorphisms contribute to PCOS susceptibility and phenotypic outcomes in Indian women. Gene, 661: 34-44. https://doi.org/10.1016/j.gene.2018.03.083
  • De Leo V, Musacchio MC, Cappelli V, Massaro MG, Morgante G, Petraglia F (2016) Genetic, hormonal and metabolic aspects of PCOS: an update. Reproductive Biology and Endocrinology, 14(1): 38. https://doi.org/10.1186/s12958-016-0173-x
  • Ehrmann DA (2005) Polycystic ovary syndrome. New England Journal of Medicine, 352(12): 1223-36. https://doi.org/10.1056/NEJMra041536
  • Elmasry SA, Al-Azzawi MA, Ghoneim AH, Nasr MY, AboZaid MM (2015) Role of oxidant–antioxidant imbalance in the pathogenesis of chronic obstructive pulmonary disease. Egyptian journal of chest diseases and tuberculosis, 64(4): 813-20. https://doi.org/10.1016/j.ejcdt.2015.06.001
  • Fuhrman B (2012) Regulation of hepatic paraoxonase-1 expression. Journal of lipids. https://doi.org/10.1155/2012/684010
  • Hayes FJ, Taylor AE, Martin KA, Hall JE (1998) Use of a gonadotropin-releasing hormone antagonist as a physiologic probe in polycystic ovary syndrome: assessment of neuroendocrine and androgen dynamics. The Journal of Clinical Endocrinology & Metabolism, 83(7): 2343-9. https://doi.org/10.1210/jcem.83.7.4925
  • Hyderali BN, Mala K (2015) Oxidative stress and cardiovascular complications in polycystic ovarian syndrome. European Journal of Obstetrics & Gynecology and Reproductive Biology, 191:15-22. https://doi.org/10.1016/j.ejogrb.2015.05.005
  • Jeelani H, Ganie MA, Parvez T, Fatima Q, Kawa IA, Rashid F (2017) Oxidative stress biomarkers in polycystic ovary syndrome (PCOS). Precision medicine, 2(1): 30-8.
  • Kheiry MV, Hafezi AM, Hesaraki S (2013) Bone Regeneration Using Nanotechnology–Calcium Silicate Nano-Composites. UCT Journal of Research in Science, Engineering and Technology, 1(1): 1-3.
  • Kim JJ, Choi YM (2013) Dyslipidemia in women with polycystic ovary syndrome. Obstetrics & gynecology science, 56(3): 137. https://doi.org/10.5468/ogs.2013.56.3.137
  • Kiranmayee D, Kavya K, Himabindu Y, Sriharibabu M, Madhuri GL, Venu S (2017) Correlations between anthropometry and lipid profile in women with PCOS. Journal of human reproductive sciences, 10(3): 167. https://doi.org/10.4103/jhrs.JHRS_108_16
  • Komoda T (Editor) (2013) The HDL handbook: biological functions and clinical implications. Academic Press.
  • Koren-Gluzer M, Aviram M, Hayek T (2013) Paraoxonase1 (PON1) reduces insulin resistance in mice fed a high-fat diet, and promotes GLUT4 overexpression in myocytes, via the IRS-1/Akt pathway. Atherosclerosis, 229(1): 71-8. https://doi.org/10.1016/j.atherosclerosis.2013.03.028
  • Koren-Gluzer M, Aviram M, Meilin E, Hayek T (2011) The antioxidant HDL-associated paraoxonase-1 (PON1) attenuates diabetes development and stimulates β-cell insulin release. Atherosclerosis, 219(2): 510-8. https://doi.org/10.1016/j.atherosclerosis.2011.07.119
  • Lim SS, Davies MJ, Norman RJ, Moran LJ (2012) Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Human reproduction update, 18(6): 618-37. https://doi.org/10.1093/humupd/dms030
  • Mah P, Webster J (2002) Hyperprolactinemia: etiology, diagnosis and management. Semin Reprod Med.: 365-74. https://doi.org/10.1055/s-2002-36709
  • Mehdi MM, Rizvi SI (2012) Human plasma paraoxonase 1 (PON1) arylesterase activity during aging: correlation with susceptibility of LDL oxidation. Archives of medical research, 43(6): 438-43. https://doi.org/10.1016/j.arcmed.2012.08.012
  • Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS (2005) Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Human Reproduction, 20(7): 1820-6. https://doi.org/10.1093/humrep/deh850
  • Rzeszowska M, Leszcz A, Putowski L, Hałabiś M, Tkaczuk-Włach J, Kotarski J, Polak G (2016) Anti-Müllerian hormone: structure, properties and appliance. Ginekologia polska, 87(9): 669-74. https://doi.org/10.5603/GP.2016.0064
  • Stracquadanio M, Ciotta L, Palumbo MA (2018) Relationship between serum anti-Mullerian hormone and intrafollicular AMH levels in PCOS women. Gynecological Endocrinology, 34(3): 223-8. https://doi.org/10.1080/09513590.2017.1381838
  • Suresh S, Vijayakumar T (2015) Correlations of insulin resistance and serum testosterone levels with LH: FSH ratio and oxidative stress in women with functional ovarian hyperandrogenism. Indian Journal of Clinical Biochemistry, 30(3): 345-50. https://doi.org/10.1007/s12291-014-0447-z
  • Zuo T, Zhu M, Xu W (2016) Roles of oxidative stress in polycystic ovary syndrome and cancers. Oxidative medicine and cellular longevity. https://doi.org/10.1155/2016/8589318

License

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.